Boston Scientific Data Engineer Salary by Level
Boston Scientific data engineer compensation by level, from individual interview and offer reports. The numbers update as more reports land, so they stay current and data-engineer-specific rather than the generic software-engineer bands most pages quote.
Data engineer total comp by level
Each level's figure is the median of individual Boston Scientific data engineer offers at that level, so it reflects a typical outcome rather than an average pulled up by a few large packages. Total comp counts base salary plus equity and bonus annualized over the vest, and the range shown is the middle half of offers, with the top and bottom quarters trimmed off. These are data-engineer figures specifically, which run below the all-software-engineer bands most comp sites quote at the same level.
The mid-band figures carry more weight than the entry-band ones here. 11 mid-level offers make $123K at L4 the most grounded number on this page; the entry-band rests on 8 reports, enough to be directionally useful but thin enough that a handful of high or low offers move the median. Across all 19 data engineer salary reports, some are verified submissions with full comp breakdowns and some are base-only public filings where bonus and equity are estimated from peer ratios at comparable medical device companies. A deeply-reported level gives you a real distribution; a thinly-reported one gives you a center of gravity. The figures updated as recently as Aug 2, 2026, which matters in a company where hiring pace has been cautious and new offers are infrequent.
Every Boston Scientific comp sample on record
One dot per reported offer, plotted against years of experience and colored by level. Toggle levels or switch between total comp and base. The spread is the honest picture the medians summarize.
Boston Scientific's comp structure at the data engineering level is base-heavy. The offers in the pool show total compensation figures that sit close to base, with limited equity upside of the kind you'd see at a software-first company. Medical device companies of this size typically deliver annual cash bonuses in the 10 to 15 percent range tied to both individual and company performance, with equity, where it exists, coming through RSU grants on multi-year vesting schedules rather than large front-loaded refreshes. What that means for realized annual pay: the headline total comp number and what you deposit in year one are close to each other, with less of the variance that RSU-heavy tech offers introduce. Engineers who want predictable annual cash will find that structure comfortable; engineers optimizing for equity accumulation over a 4 year vest will find the ceiling lower than they'd expect.
Culture and sentiment at Boston Scientific
What the offer feels like from the inside, not just the number. Glassdoor and forum readings plus happiness and layoff-risk signals, updated as new data lands.
At $123K for a mid-level data engineer, Boston Scientific pay lands slightly below other Technology companies, and the mechanism is straightforward. Boston Scientific competes for data engineering talent against other medical device and life sciences employers in the Marlborough corridor, where the reference salary frame is MedTech peers, not hyperscalers or fintech firms. Companies in regulated industries with stable, growing revenue but modest software-talent urgency tend to set comp bands through internal job architecture rather than real-time market benchmarking, which produces durable discounts to tech-sector rates. The likeliest read here is that Boston Scientific has decided it can fill data engineering roles at these figures by attracting engineers who value domain stability and mission over total comp, and the applicant pool has borne that out. That's a deliberate position, consistent with how the broader compensation philosophy appears to work across the company.
Glassdoor and forum readings are third-party aggregates; the happiness and layoff-risk tiers are modeled weekly from primary signals.
How the offer level (and the comp curve) is decided
Your level is set during the loop, before team match. The band widens with seniority, so the same performance lands very different comp depending on which curve you get placed on.
The single most consequential decision a candidate can make before negotiating is picking the right target level. With only 2 rungs, the gap between entry and mid is the primary lever available, and the medians are closer than you'd expect: both sit at $123K and $123K respectively, which means the negotiating argument for mid is framing your years of experience and pipeline ownership clearly, not chasing a salary gap that may not be there. Base is the component most likely to flex in an initial offer; equity is minimal enough that it's rarely the crux of a negotiation at this company. A competing offer from another medical device or life sciences employer carries more weight here than one from a hyperscaler, because the comp comparison is seen as relevant. If you're holding an offer, the highest-value move is to come in with a peer-sector number and ask specifically about base band ceiling rather than total comp.
Recruiter calibration
The recruiter sets a target level from your experience and project scope, and shares a band. The band is a bracket, not the offer.
Interview loop ✕
Performance sets your final level. Strong rounds bump you a level; a weak round drops you. This is where the comp curve is decided.
Debrief / committee
Interviewers compare notes and set level and band. Consistency across rounds matters as much as any single strong one.
Offer + negotiation
Base, bonus, equity, and sign-on are visible. Equity usually has the widest band and is the main lever; a written competing offer moves it most.
Reading the equity, not just the headline number
The most misread part of a big-tech offer is the equity curve. A multi-year RSU grant is not a flat annual number, and what you negotiate should account for how it vests and refreshes.
Your offer includes a 4-year RSU grant worth $240K. What is your equity income in Year 4, and what should you actually negotiate?
Works out the vest: roughly $60K/yr if it vests evenly, and recognizes the original grant ends after 4 years, so without refreshers equity income drops in Year 4-5.
Negotiates the equity grant and the refresher expectation, not just base, and notes the grant is fixed in shares at signing so the dollar value floats with the stock.
Assumes the RSU value is a fixed cash amount that continues forever, and negotiates only base.
Ignores refreshers and stock movement, so the Year-4 drop is a surprise.
How Boston Scientific pay splits: base, bonus, equity
The composition behind each level's total comp, from individual offer reports. Equity is the lever that grows with seniority.
Median base, bonus, and annualized equity per level from individual Boston Scientific offer reports. The equity share climbs sharply at senior levels. the headline total moves with the stock, not the base.